GALAPAGOS NV

GLPG
Real-time Quote. Real-time  - 01/14 11:35:44 am
47.785EUR +3.42%

Turn to zoom
Prev.47.7850
Open45.7500
High48.1400
Low45.6500
Volume431 897
Latest news
2d ago
3d ago
3d ago
6d ago
Chart GALAPAGOS NV
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBearish
Resistance49,251,960,1
Spread/Res.-2,9%-8,0%-21%
Spread/Supp.10%15%15%
Support43,441,741,7
Financials
Sales 2021 485 M 553 M 553 M
Net income 2021 -182 M -208 M -208 M
Net cash 2021 3 984 M 4 545 M 4 545 M
P/E ratio 2021 -18,0x
Yield 2021 -
Capitalization 3 132 M 3 578 M 3 573 M
EV / Sales 2021 -1,76x
EV / Sales 2022 -0,82x
Nbr of Employees 1 319
Free-Float 74,5%
Company
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2022-02-14 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 9
Last Close Price 47,79 €
Average target price 55,56 €
Spread / Average Target 16,3%